Treatment failure and hospital readmissions in severe COPD exacerbations treated with azithromycin versus placebo – a post-hoc analysis of the BACE randomized controlled trial

BACKGROUND: In the BACE trial, a 3-month (3 m) intervention with azithromycin, initiated at the onset of an infectious COPD exacerbation requiring hospitalization, decreased the rate of a first treatment failure (TF); the composite of treatment intensification (TI), step-up in hospital care (SH) and...

Descripción completa

Detalles Bibliográficos
Autores principales: Vermeersch, Kristina, Belmans, Ann, Bogaerts, Kris, Gyselinck, Iwein, Cardinaels, Nina, Gabrovska, Maria, Aumann, Joseph, Demedts, Ingel K., Corhay, Jean-Louis, Marchand, Eric, Slabbynck, Hans, Haenebalcke, Christel, Vermeersch, Stefanie, Verleden, Geert M., Troosters, Thierry, Ninane, Vincent, Brusselle, Guy G., Janssens, Wim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6819655/
https://www.ncbi.nlm.nih.gov/pubmed/31665017
http://dx.doi.org/10.1186/s12931-019-1208-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6819655/
https://www.ncbi.nlm.nih.gov/pubmed/31665017
http://dx.doi.org/10.1186/s12931-019-1208-6

Ejemplares similares